Relay Therapeutics
Applies structural biology and computational chemistry to target protein motion.
What they do
Relay Therapeutics integrates experimental and computational technologies to analyze protein motion. Their platform enables the design of precision medicines that target complex protein conformations, delivering therapeutic solutions to oncology and genetic disease patients.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Structure based design
- Product type
- Platform software
- Stage
- Public
- Headquarters
- Cambridge, United States
- Region
- North America
- Founded
- 2015
- Total funding
- $520M raised
Notable investors: SoftBank Vision Fund, Third Rock Ventures, T. Rowe Price, Fidelity Management.